Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
bio
2
×
crispr
2025
ad-comm
affimed
akcea therapeutics
allogene therapeutics
amicus therapeutics
approval
apremilast
base editing
bill gates
biogen
biome
biotech
blueprint medicineas
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
briefing docs
car-t
celgene
cervical cancer
clinical study
clinical trial
commissioner
crispr therapeutics
cybersecurity
democrats
detection
detroit blog main
detroit top stories
digital health
diversity
donald trump
editas medicine
endpoints
fail
failure
What
crispr
nearly
shares
2
×
allogene
believe
bio
biotech
built
cancer
company’s
concerns
debut
dispute
diversity
drop
drops
editas
editing
far
gene
hot
hours
immunotherapy
investors
ipo
ipo’s
juno
legally
million
new
outfit
patent
percent
plummeted
public
read
remains
roundup
shortly
skyrocketing
Language
Current search:
shares
×
bio
×
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@techcrunch.com
8 years ago
Editas biotech stock drops by 26% over CRISPR patent dispute
